All In Biotech

Drug Trial Radar · NCT07387367

A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

A Phase 3, Multicenter, Prospective, Randomized, Open-label Efficacy and Safety Study of Intravenous Brincidofovir Versus Intravenous Cidofovir for Treatment of Adenovirus Infection in Pediatric and Adult Subjects After Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 180 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

180

Planned (sponsor's estimate)

Start

Mar 17, 2026

Primary completion

Jan 31, 2028

Study completion Jun 30, 2028

Sponsor

Lead sponsor
SymBio PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Feb 4, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized, open-label, parallel group, two-arm, multi-center assessment will compare IV BCV with IV CDV in adult and pediatric allogeneic HCT recipients with AdV viremia. A virologic response-driven approach to duration of treatment will be evaluated, in which randomized subjects are treated with either BCV or CDV until AdV viremia is confirmed as undetectable or until a maximum of 12 weeks of therapy, whichever occurs first. All subjects will be followed for a total of 24 weeks post-randomization, regardless of treatment assignment. Subjects will be assessed on a weekly basis through the end of treatment visit (EOT). Additional assessments will be performed at the test of cure (TOC) visit, which is 4 weeks after the last dose of study drug and at Weeks 12 and 24 post W1D1.

Conditions

  • Adenovirus Infections

Interventions

  • cidofovirDrug

    CDV does not have a labeled indication for treating Adenovirus infection. CDV will be administered according to local guidelines and institutional standard of care practice.

  • BrincidofovirDrug

    Intravenous

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess efficacy of intravenous (IV) brincidofovir (BCV), compared with IV cidofovir (CDV), in subjects after allo-HCT with adenovirus (AdV) viremia.Time frame: Week (W) 5 Day (D) 1.

Locations

81 sites in 13 countries. Site status is shown where the registry gives one.

  • Phoenix Children's Hospital

    Phoenix, Arizona · Recruiting

  • City of Hope

    Duarte, California · Recruiting

  • Stanford Medicine Children's Health

    Palo Alto, California · Recruiting

  • University of California Davis

    Sacramento, California · Recruiting

  • Rady Children's Hospital

    San Diego, California · Recruiting

  • Children's Hospital Colorado-Center for Cancer and Blood Disorders

    Aurora, Colorado · Recruiting

  • Children's National Hospital

    Washington D.C., District of Columbia · Recruiting

  • Johns Hopkins All Children's Hospital

    St. Petersburg, Florida · Not yet recruiting

  • Children's Healthcare of Atlanta

    Atlanta, Georgia · Recruiting

  • Ann and Robert H Lurie Children's Hospital

    Chicago, Illinois · Recruiting

  • University of Chicago

    Chicago, Illinois · Not yet recruiting

  • Riley Children's Health (Indiana University)

    Indianapolis, Indiana · Recruiting

  • Dana-Farber Cancer Institute-Brighman and Women's

    Boston, Massachusetts · Recruiting

  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center

    Boston, Massachusetts · Recruiting

  • Helen Devos Children's Hospital / Michigan State University

    Grand Rapids, Michigan · Not yet recruiting

  • University of Minnesota

    Minneapolis, Minnesota · Recruiting

  • St Louis Children's Hospital - Barnes Jewish Hospital

    St Louis, Missouri · Recruiting

  • University of Nebraska

    Omaha, Nebraska · Recruiting

  • Joseph M Sanzari Children's Hospital

    Hackensack, New Jersey · Recruiting

  • Cohen Children's Medical Center

    New Hyde Park, New York · Recruiting

  • Columbia University Irving Medical Center

    New York, New York · Not yet recruiting

  • Weill Cornell Medicine

    New York, New York · Recruiting

  • Duke University Medical Center

    Durham, North Carolina · Recruiting

  • Cincinnati Children's Hospital

    Cincinnati, Ohio · Recruiting

  • Nationwide Children's Hospital

    Columbus, Ohio · Not yet recruiting

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania · Recruiting

  • University of Pittsburgh Medical Center Children's Hospital

    Pittsburgh, Pennsylvania · Not yet recruiting

  • St. Jude Children's Research Hospital

    Memphis, Tennessee · Recruiting

  • UT Southwestern Medical Center

    Dallas, Texas · Not yet recruiting

  • Seattle Children's Hospital

    Seattle, Washington · Recruiting

  • Fred Hutchinson Cancer Center

    Seattle, Washington · Recruiting

  • Medical College of Wisconsin / Children's Wisconsin

    Milwaukee, Wisconsin · Recruiting

  • St. Anna Kinderspital- Childrens Hospital

    Vienna, Austria · Not yet recruiting

  • Leuven, University Hospital Gasthuisberg

    Leuven, Belgium · Not yet recruiting

  • Centre Hospitalier Universitaire (CHU) de Liège

    Liège, Belgium · Not yet recruiting

  • Alberta Children's Hospital University of Calgary

    Calgary, Canada · Recruiting

  • CHU Sainte Justine Hospital

    Montreal, Canada · Recruiting

  • The Hospital for Sick Children

    Toronto, Canada · Recruiting

  • University Health Network- Princess Margaret Cancer Centre

    Toronto, Ontario Province, Canada · Recruiting

  • Hopital Maisonneuve-Rosemont - CIUSSS de l Est de L Ile de Montreal

    Montreal, Quebec Province, Canada · Recruiting

Showing 40 of 81 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.